The strategy of pharmaceutical investment promotion companies should also focus on service

Today's brand means network, brand means value, brand means market, brand means value added, brand means the future, non-branded companies are in fact not competitive, and are bound to decline. The construction of the investment promotion brand should become the eternal pursuit of the operation of the investment enterprise. The effective establishment of the investment promotion brand is conducive to the continuous and healthy development of the enterprise, the continuous introduction of new products for the enterprise, the continuous consolidation of the market network for the pharmaceutical investment enterprise, and the continuous improvement of the sales of the enterprise. Has an irreplaceable role. Under the new situation, pharmaceutical investment promotion companies are constantly making strategic and tactical innovations. However, regardless of the ever-changing creativity, the prerequisite must be to adapt to the company and start from the basics.

In the form of pharmaceutical investment promotion, medical agent experts believe that for some well-known brand products, they may consider choosing auction methods for investment promotion. From the perspective of the impact of the new medical reforms on channels, the clinical channels and the specialty medicine market derived therefrom will be the channels through which pharmaceutical investment enterprises can focus their efforts. The basic drug markets and OTC markets that are affected by the policies need to be carefully considered.

In the opinion of pharmaceutical investment experts, there are many reasons why the two sides have not cooperate since the cooperation between the pharmaceutical investment enterprise and the customers. However, the failure of pharmaceutical companies to rationalize the relationship between service and restrictions is one of the reasons for the loss of customers. Pharmaceutical companies should understand that the key to marketing is to provide services to customers. They should put services first and then consider the constraints. In order to encourage customers to distribute their products, a pharmaceutical company promises to rebate to customers in a certain proportion after completing certain sales.

Then the personnel of the pharmaceutical investment enterprise should be recognized. If you want to gain prestige, you must let the people around you recognize you; modesty is the prerequisite for you to obtain the recognition of others. People need to respect, whether it is your superior or subordinate, Whether it is a cooperative relationship or a supply-demand relationship, and dealing with people, the modest attitude you exhibit is itself a respect for others. Especially in dealings with your customers, the modest attitude will win the customer's high degree of cooperation and recognition; in communicating with your subordinates, the modesty attitude is an affable performance for the subordinates. To allow others to recognize, you should Being professional enough, professionalism is fundamental to your respect for others, and it is a prerequisite for building personal credibility.

In the current investment promotion media, some media have their advantages in terms of customer resources and distribution channels that are incomparable to other media and have established cooperative relationships with these investment media. In addition, pharmaceutical investment is not only a telephone sales skill and skill, a good display of team-to-corporate image, specification of contract details, perfection of distributor database, skills of pharmaceutical investment advertisement, budget of pharmaceutical investment, service to dealers, etc. The key links for investment promotion are indispensable.

In recent years, because of the incomplete qualifications of certain pharmaceutical investment enterprises, the production of counterfeit medicines and unqualified medicines endanger people’s lives, and the selection of a well-known and well-recognized pharmaceutical manufacturer can at least come from the source. To reduce this possibility, even if something goes wrong, such large manufacturers will certainly help dealers deal with these problems in the first place.

In order to motivate and restrain customers, pharmaceutical investment enterprises will achieve their own goals through various means, such as signing effective contracts and agreements, and even requiring customers to pay certain deposits. However, in the actual pharmaceutical investment promotion process, it is not difficult for drug companies to find that most customers want to cooperate with themselves, but they are not willing to be subject to "regulations and restrictions." The drug company said that it will automatically return the bond to the customer when the contract is terminated. This is where the good faith lies. Therefore, in the process of investment promotion, pharmaceutical investment promotion companies are required to serve the customers, but it is also necessary to protect the interests of both parties and to “get the gentleman first” so as to avoid unnecessary trouble in the future.

In the view of pharmaceutical agents, there have been many reasons why the two sides have failed to cooperate with each other after the cooperation between pharmaceutical investment enterprises and customers. However, the failure of pharmaceutical companies to rationalize the relationship between service and restrictions is one of the reasons for the loss of customers. Pharmaceutical companies should understand that the key to marketing is to provide services to customers. They should put services first and then consider the constraints. In order to encourage customers to distribute their products, a pharmaceutical company promises to rebate to customers in a certain proportion after completing certain sales.